Literature DB >> 26590718

[KIL-d] Protein Element Confers Antiviral Activity via Catastrophic Viral Mutagenesis.

Genjiro Suzuki1, Jonathan S Weissman2, Motomasa Tanaka3.   

Abstract

Eukaryotic cells are targeted by pathogenic viruses and have developed cell defense mechanisms against viral infection. In yeast, the cellular extrachromosomal genetic element [KIL-d] alters killer activity of M double-stranded RNA killer virus and confers cell resistance against the killer virus. However, its underlying mechanism and the molecular nature of [KIL-d] are unknown. Here, we demonstrate that [KIL-d] is a proteinaceous prion-like aggregate with non-Mendelian cytoplasmic transmission. Deep sequencing analyses revealed that [KIL-d] selectively increases the rate of de novo mutation in the killer toxin gene of the viral genome, producing yeast harboring a defective mutant killer virus with a selective growth advantage over those with WT killer virus. These results suggest that a prion-like [KIL-d] element reprograms the viral replication machinery to induce mutagenesis and genomic inactivation via the long-hypothesized mechanism of "error catastrophe." The findings also support a role for prion-like protein aggregates in cellular defense and adaptation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26590718      PMCID: PMC5513702          DOI: 10.1016/j.molcel.2015.10.020

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  36 in total

1.  Error catastrophe and antiviral strategy.

Authors:  Manfred Eigen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

2.  Conformational variations in an infectious protein determine prion strain differences.

Authors:  Motomasa Tanaka; Peter Chien; Nariman Naber; Roger Cooke; Jonathan S Weissman
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

3.  Heritable remodeling of yeast multicellularity by an environmentally responsive prion.

Authors:  Daniel L Holmes; Alex K Lancaster; Susan Lindquist; Randal Halfmann
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

4.  The occurrence of killer character in yeasts of various genera.

Authors:  G Philliskirk; T W Young
Journal:  Antonie Van Leeuwenhoek       Date:  1975       Impact factor: 2.271

5.  KAR1, a gene required for function of both intranuclear and extranuclear microtubules in yeast.

Authors:  M D Rose; G R Fink
Journal:  Cell       Date:  1987-03-27       Impact factor: 41.582

6.  A yeast prion, Mod5, promotes acquired drug resistance and cell survival under environmental stress.

Authors:  Genjiro Suzuki; Naoyuki Shimazu; Motomasa Tanaka
Journal:  Science       Date:  2012-04-20       Impact factor: 47.728

Review 7.  Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications.

Authors:  Marco Vignuzzi; Jeffrey K Stone; Raul Andino
Journal:  Virus Res       Date:  2005-02       Impact factor: 3.303

8.  Molecular cloning and analysis of yeast gene for cycloheximide resistance and ribosomal protein L29.

Authors:  H M Fried; J R Warner
Journal:  Nucleic Acids Res       Date:  1982-05-25       Impact factor: 16.971

9.  Chromosomal and nonchromosomal mutations affecting the "killer character" of Saccharomyces cerevisiae.

Authors:  R B Wickner
Journal:  Genetics       Date:  1974-03       Impact factor: 4.562

10.  Functional amyloidogenesis and cytotoxicity-insights into biology and pathology.

Authors:  Douglas M Fowler; Jeffery W Kelly
Journal:  PLoS Biol       Date:  2012-12-27       Impact factor: 8.029

View more
  2 in total

1.  Meiotic viral attenuation through an ancestral apoptotic pathway.

Authors:  Jie Gao; Sabrina Chau; Fuad Chowdhury; Tina Zhou; Saif Hossain; G Angus McQuibban; Marc D Meneghini
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-02       Impact factor: 11.205

2.  Adaptive evolution of nontransitive fitness in yeast.

Authors:  Sean W Buskirk; Alecia B Rokes; Gregory I Lang
Journal:  Elife       Date:  2020-12-29       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.